| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.
|
J Exp Med
|
2011
|
4.37
|
|
2
|
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia.
|
Blood
|
2007
|
3.64
|
|
3
|
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia.
|
Blood
|
2014
|
2.53
|
|
4
|
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.
|
Blood
|
2011
|
2.44
|
|
5
|
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype.
|
Blood
|
2008
|
2.13
|
|
6
|
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.
|
Blood
|
2011
|
2.04
|
|
7
|
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
|
Blood
|
2011
|
2.02
|
|
8
|
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.
|
Blood
|
2012
|
1.88
|
|
9
|
Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases.
|
Blood
|
2009
|
1.74
|
|
10
|
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
|
Haematologica
|
2011
|
1.67
|
|
11
|
Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission.
|
Leuk Lymphoma
|
2007
|
1.41
|
|
12
|
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.
|
Blood
|
2006
|
1.41
|
|
13
|
Protein kinase gene expression profiling and in vitro functional experiments identify novel potential therapeutic targets in adult acute lymphoblastic leukemia.
|
Cancer
|
2010
|
1.40
|
|
14
|
Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
|
Haematologica
|
2002
|
1.39
|
|
15
|
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol.
|
Blood
|
2005
|
1.24
|
|
16
|
Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
|
Genes Chromosomes Cancer
|
2009
|
1.21
|
|
17
|
Clinical implications of the molecular genetics of chronic lymphocytic leukemia.
|
Haematologica
|
2013
|
1.17
|
|
18
|
Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
|
Genes Chromosomes Cancer
|
2011
|
1.17
|
|
19
|
The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response.
|
Cancer Res
|
2003
|
1.11
|
|
20
|
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness.
|
Blood
|
2014
|
1.09
|
|
21
|
Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis.
|
Haematologica
|
2010
|
1.09
|
|
22
|
Clinical features and outcome of familial chronic lymphocytic leukemia.
|
Haematologica
|
2006
|
1.05
|
|
23
|
Gene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223.
|
Haematologica
|
2010
|
1.04
|
|
24
|
The changing scene of adult acute lymphoblastic leukemia.
|
Curr Opin Oncol
|
2006
|
1.03
|
|
25
|
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts.
|
Haematologica
|
2013
|
1.01
|
|
26
|
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
|
Leuk Lymphoma
|
2011
|
1.01
|
|
27
|
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study.
|
Blood
|
2007
|
0.99
|
|
28
|
Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukaemia patients.
|
Hematol Oncol
|
2009
|
0.99
|
|
29
|
Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2.
|
Genes Cancer
|
2011
|
0.99
|
|
30
|
Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults.
|
Haematologica
|
2010
|
0.98
|
|
31
|
White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia.
|
Haematologica
|
2010
|
0.98
|
|
32
|
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
|
Haematologica
|
2007
|
0.98
|
|
33
|
Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia.
|
Haematologica
|
2006
|
0.98
|
|
34
|
IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment.
|
Blood
|
2003
|
0.97
|
|
35
|
New developments in the diagnosis, prognosis and treatment of chronic lymphocytic leukemia.
|
Curr Opin Oncol
|
2005
|
0.97
|
|
36
|
TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy.
|
Haematologica
|
2013
|
0.96
|
|
37
|
Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
|
Haematologica
|
2005
|
0.95
|
|
38
|
The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
|
Br J Haematol
|
2005
|
0.94
|
|
39
|
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
|
Genes Chromosomes Cancer
|
2011
|
0.93
|
|
40
|
A mechanism-driven treatment for chronic lymphocytic leukemia?
|
N Engl J Med
|
2013
|
0.92
|
|
41
|
Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia.
|
Br J Haematol
|
2003
|
0.92
|
|
42
|
Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly.
|
Br J Haematol
|
2008
|
0.91
|
|
43
|
B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
|
Transplantation
|
2008
|
0.89
|
|
44
|
ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications.
|
Blood
|
2005
|
0.87
|
|
45
|
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
|
Blood
|
2012
|
0.87
|
|
46
|
Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
|
Haematologica
|
2008
|
0.87
|
|
47
|
Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitro.
|
Br J Haematol
|
2004
|
0.87
|
|
48
|
Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors.
|
Blood
|
2002
|
0.87
|
|
49
|
A subset of chronic lymphocytic leukemia patients display reduced levels of PARP1 expression coupled with a defective irradiation-induced apoptosis.
|
Exp Hematol
|
2011
|
0.86
|
|
50
|
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.
|
Am J Hematol
|
2014
|
0.86
|
|
51
|
Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR.
|
Br J Haematol
|
2014
|
0.85
|
|
52
|
Defective expression of the T-cell receptor-CD3 zeta chain in T-cell acute lymphoblastic leukaemia.
|
Br J Haematol
|
2003
|
0.84
|
|
53
|
Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients.
|
Cancer Immunol Immunother
|
2014
|
0.84
|
|
54
|
Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.
|
Genes Chromosomes Cancer
|
2015
|
0.83
|
|
55
|
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes.
|
Br J Haematol
|
2011
|
0.83
|
|
56
|
An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia.
|
Haematologica
|
2009
|
0.83
|
|
57
|
Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
|
Haematologica
|
2007
|
0.82
|
|
58
|
Negative impact of FLT3 abnormalities in elderly acute myeloid leukemia patients.
|
Leuk Lymphoma
|
2008
|
0.81
|
|
59
|
High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation.
|
Haematologica
|
2011
|
0.80
|
|
60
|
Identification of molecular and functional patterns of p53 alterations in chronic lymphocytic leukemia patients in different phases of the disease.
|
Haematologica
|
2012
|
0.80
|
|
61
|
Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors.
|
Leuk Res
|
2009
|
0.80
|
|
62
|
Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
|
Am J Hematol
|
2014
|
0.80
|
|
63
|
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage.
|
Br J Haematol
|
2011
|
0.80
|
|
64
|
Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy alone.
|
Leuk Lymphoma
|
2006
|
0.79
|
|
65
|
FLT3 inhibition in t(4;11)+ adult acute lymphoid leukaemia.
|
Br J Haematol
|
2005
|
0.79
|
|
66
|
Identification of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients.
|
Blood
|
2009
|
0.79
|
|
67
|
The immune reconstitution after an allogeneic stem cell transplant correlates with the risk of graft-versus-host disease and cytomegalovirus infection.
|
Leuk Res
|
2011
|
0.79
|
|
68
|
IgD cross-linking induces gene expression profiling changes and enhances apoptosis in chronic lymphocytic leukemia cells.
|
Leuk Res
|
2013
|
0.78
|
|
69
|
Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission.
|
Br J Haematol
|
2002
|
0.78
|
|
70
|
Immunocompetent cell functions in Ph+ acute lymphoblastic leukemia patients on prolonged Imatinib maintenance treatment.
|
Cancer Immunol Immunother
|
2011
|
0.78
|
|
71
|
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance.
|
Hematol Oncol
|
2013
|
0.77
|
|
72
|
AICDA expression in BCR/ABL1-positive acute lymphoblastic leukaemia is associated with a peculiar gene expression profile.
|
Br J Haematol
|
2011
|
0.77
|
|
73
|
Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocytic leukemia cells.
|
Ann Hematol
|
2014
|
0.77
|
|
74
|
NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.
|
Leuk Lymphoma
|
2014
|
0.76
|
|
75
|
Functional analysis and gene expression profile of umbilical cord blood regulatory T cells.
|
Ann Hematol
|
2011
|
0.76
|
|
76
|
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.
|
J Hematol Oncol
|
2013
|
0.76
|
|
77
|
Is the aberrant expression of p53 by immunocytochemistry a surrogate marker of TP53 mutation and/or deletion in chronic lymphocytic leukemia?
|
Am J Clin Pathol
|
2011
|
0.76
|
|
78
|
Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation.
|
Leuk Res
|
2006
|
0.75
|
|
79
|
A broad and integrated diagnostic work-up for a modern management of Acute Lymphoblastic Leukemia (ALL).
|
Hematology
|
2005
|
0.75
|
|
80
|
A lymphotactin-producing monoclonal T-cell lymphoproliferative disorder with extreme lymphocytopenia and progressive leukoencephalopathy.
|
Leuk Lymphoma
|
2006
|
0.75
|
|
81
|
Rituximab in previously treated primary immune thrombocytopenia patients: evaluation of short- and long-term efficacy and safety.
|
Acta Haematol
|
2013
|
0.75
|
|
82
|
A case of late isolated ovarian relapse of acute lymphoblastic leukemia after an allogeneic stem cell transplant.
|
Leuk Lymphoma
|
2014
|
0.75
|
|
83
|
Clinical responses in allografted acute leukaemia patients with resistant disease using a combined chemo-immunotherapeutic treatment strategy.
|
Br J Haematol
|
2010
|
0.75
|
|
84
|
Whole-genome amplification for the detection of molecular targets and minimal residual disease monitoring in acute lymphoblastic leukaemia.
|
Br J Haematol
|
2014
|
0.75
|
|
85
|
Haemolytic uremic syndrome during induction therapy in an acute promyelocytic leukemia patient with aberrant phenotype: a possible manifestation of retinoic acid syndrome.
|
Leuk Lymphoma
|
2007
|
0.75
|